结核病管理中的基于皮里米丁的化合物:对它们的生物和药物重要性的一次审查
Deepshikha Singh1, Vikram Singh2, Afrasim Moin3
1Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysore - 570015, Karnataka, India.
Medicinal chemistry (Shariqah (United Arab Emirates))
|March 25, 2025
概括
科学家们正在开发新胺衍生物来对抗结核病 (TB),包括耐药菌株. 本综述强调了结核病治疗有效性的临床试验中的结构-活性关系和新药候选药物.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 有机化学 有机化学
背景情况:
- 胺衍生物是具有广泛生物活性的多功能异环化合物,包括抗结核潜力.
- 耐药性多种结核菌菌 (MTB) 的增加需要开发新的抗结核药物.
- 现有的第一线抗结核病药物对抗耐药菌株的效果越来越差.
研究的目的:
- 审查和识别具有潜在抗结核活性的新型胺衍生物.
- 分析这些含胺的化合物的结构-活性关系 (SAR).
- 为了概述目前基于pyrimidine的抗结核病药物发现的进展.
主要方法:
- 对研究抗结核性质的胺基衍生物的文献综述.
- 在科学文献中报告的结构-活动关系 (SAR) 的分析.
- 鉴定目前正在临床试验中的胺基化合物.
主要成果:
- 几种皮里米丁衍生物显示出对药物敏感性和耐药性MTB有前途的抗结核活性.
- 通过SAR研究,已经确定了对抗结核病有效性的关键结构特征.
- 三种基于金胺的候选药物 (GSK-286,TBA-7371,SPR-720) 正在临床开发中.
结论:
- 胺衍生物代表了开发新的抗结核病疗法的有希望的支架.
- 对胺基化合物的进一步研究对于应对耐药结核病的挑战至关重要.
- 在临床试验中发现的候选药物为改善结核病治疗策略提供了希望.
更多相关视频
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.4K
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.7K
相关概念视频
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis I
212
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
212
Pulmonary Tuberculosis III
282
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
282
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
